|
US7157555B1
(en)
*
|
1997-08-08 |
2007-01-02 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
|
US7829084B2
(en)
*
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
EP2272864A3
(en)
|
2002-12-20 |
2011-02-16 |
Amgen Inc. |
Binding agents which inhibit myostatin
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
DE602004031390D1
(de)
|
2003-05-06 |
2011-03-24 |
Syntonix Pharmaceuticals Inc |
Gerinnungsfaktor VII-Fc chimäre Proteine zur Behandlung von hämostatischen Krankheiten
|
|
US7850970B2
(en)
|
2003-08-26 |
2010-12-14 |
The Regents Of The University Of Colorado |
Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
|
|
BRPI0406606A
(pt)
|
2003-11-13 |
2005-12-06 |
Hanmi Pharm Ind Co Ltd |
Composição farmacêutica compreendendo uma região fc de imunoglobulina como um veìculo
|
|
US8110665B2
(en)
|
2003-11-13 |
2012-02-07 |
Hanmi Holdings Co., Ltd. |
Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
|
|
US8263084B2
(en)
*
|
2003-11-13 |
2012-09-11 |
Hanmi Science Co., Ltd |
Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
|
|
KR101135244B1
(ko)
*
|
2007-11-29 |
2012-04-24 |
한미사이언스 주식회사 |
인슐린 분비 펩타이드 결합체를 포함하는 비만 관련질환 치료용 조성물
|
|
HUE055861T2
(hu)
|
2004-04-21 |
2021-12-28 |
Alexion Pharma Inc |
Csontbejuttató konjugátumok és azok alkalmazási módszere fehérjék csonthoz kötéséhez
|
|
US20070081984A1
(en)
|
2005-10-11 |
2007-04-12 |
Shunji Tomatsu |
Compositions and methods for treating hypophosphatasia
|
|
JP2008505928A
(ja)
*
|
2004-07-08 |
2008-02-28 |
アムジェン インコーポレーテッド |
治療用ペプチド
|
|
WO2006036834A2
(en)
|
2004-09-24 |
2006-04-06 |
Amgen Inc. |
MODIFIED Fc MOLECULES
|
|
KR100594607B1
(ko)
*
|
2004-11-03 |
2006-06-30 |
재단법인서울대학교산학협력재단 |
신규한 경구투여용 재조합 인간 성장호르몬 분비미생물제제 및 그 제조방법
|
|
EP1833510A4
(en)
*
|
2004-12-27 |
2010-02-10 |
Progenics Pharmaceuticals Neva |
ORAL ADMINISTRATION ANTITOXIN ANTIBODIES AND METHODS OF MAKING AND USING THE SAME
|
|
EP1858923A4
(en)
*
|
2005-02-14 |
2008-10-15 |
Apollo Life Sciences Ltd |
MOLECULAR AND CHIMERAL MOLECULES FROM IT
|
|
KR100754667B1
(ko)
|
2005-04-08 |
2007-09-03 |
한미약품 주식회사 |
비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물
|
|
US7833979B2
(en)
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
HUE026303T2
(hu)
*
|
2005-07-25 |
2016-06-28 |
Emergent Product Dev Seattle |
B-sejt csökkentés CD37-specifikus és CD20-specifikus kapcsoló molekulák alkalmazásával
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
WO2007021129A1
(en)
*
|
2005-08-16 |
2007-02-22 |
Hanmi Pharmaceutical Co., Ltd. |
A method for the mass production of immunoglobulin fc region deleted initial methionine residues
|
|
KR100824505B1
(ko)
*
|
2005-08-16 |
2008-04-22 |
한미약품 주식회사 |
개시 메티오닌 잔기가 제거된 면역글로불린 Ｆｃ 영역의대량 생산방법
|
|
CN101534865A
(zh)
*
|
2005-10-19 |
2009-09-16 |
Ibc药品公司 |
生物活性装配体的制备方法及其用途
|
|
CA2630415A1
(en)
*
|
2005-10-20 |
2007-04-26 |
The Scripps Research Institute |
Fc labeling for immunostaining and immunotargeting
|
|
AR056142A1
(es)
*
|
2005-10-21 |
2007-09-19 |
Amgen Inc |
Metodos para generar el anticuerpo igg monovalente
|
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
|
US10155816B2
(en)
*
|
2005-11-28 |
2018-12-18 |
Genmab A/S |
Recombinant monovalent antibodies and methods for production thereof
|
|
US20070149458A1
(en)
*
|
2005-12-06 |
2007-06-28 |
Amgen Inc. |
Uses of myostatin antagonists
|
|
CN101002945B
(zh)
|
2006-01-20 |
2012-09-05 |
清华大学 |
一种用于肿瘤治疗的新型复合物
|
|
CN100475270C
(zh)
|
2006-01-20 |
2009-04-08 |
清华大学 |
一种治疗肿瘤的药物及其应用
|
|
CN105837690A
(zh)
*
|
2006-06-12 |
2016-08-10 |
新兴产品开发西雅图有限公司 |
具有效应功能的单链多价结合蛋白
|
|
ES2755386T5
(es)
*
|
2006-08-28 |
2023-04-05 |
Ares Trading Sa |
Proceso para la purificación de proteínas que contienen fragmentos Fc
|
|
US20140147441A1
(en)
*
|
2006-09-12 |
2014-05-29 |
The General Hospital Corporation |
Compositions containing alpha-1-antitrypsin and methods for use
|
|
WO2008088422A2
(en)
|
2006-10-25 |
2008-07-24 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
US20080181903A1
(en)
*
|
2006-12-21 |
2008-07-31 |
Pdl Biopharma, Inc. |
Conjugate of natriuretic peptide and antibody constant region
|
|
JP2008169195A
(ja)
*
|
2007-01-05 |
2008-07-24 |
Hanmi Pharmaceutical Co Ltd |
キャリア物質を用いたインスリン分泌ペプチド薬物結合体
|
|
CN101219219B
(zh)
|
2007-01-10 |
2013-02-13 |
北京普罗吉生物科技发展有限公司 |
包含血管抑素或其片段的复合物、其制备方法及应用
|
|
US20080238882A1
(en)
*
|
2007-02-21 |
2008-10-02 |
Ramesh Sivarajan |
Symmetric touch screen system with carbon nanotube-based transparent conductive electrode pairs
|
|
TWI573802B
(zh)
|
2007-03-06 |
2017-03-11 |
安美基公司 |
變異之活動素受體多肽及其用途
|
|
US8501678B2
(en)
|
2007-03-06 |
2013-08-06 |
Atara Biotherapeutics, Inc. |
Variant activin receptor polypeptides and uses thereof
|
|
EP2162540A2
(en)
|
2007-05-22 |
2010-03-17 |
Amgen Inc. |
Compositions and methods for producing bioactive fusion proteins
|
|
EP3176264B1
(en)
*
|
2007-05-30 |
2018-09-26 |
Postech Academy-Industry- Foundation |
Immunoglobulin fusion proteins
|
|
EP2167669A2
(en)
*
|
2007-05-31 |
2010-03-31 |
Genmab A/S |
Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals
|
|
EP2185589B1
(en)
|
2007-06-01 |
2016-01-06 |
University of Maryland, Baltimore |
Immunoglobulin constant region fc receptor binding agents
|
|
EP2162464A1
(en)
*
|
2007-06-06 |
2010-03-17 |
Boehringer Ingelheim International GmbH |
Natriuretic fusion proteins
|
|
CA2691322A1
(en)
*
|
2007-06-12 |
2008-12-24 |
Wyeth |
Anti-cd20 therapeutic compositions and methods
|
|
JP2010532764A
(ja)
*
|
2007-07-06 |
2010-10-14 |
トゥルビオン・ファーマシューティカルズ・インコーポレーテッド |
Ｃ末端に配置された特異的結合性ドメインを有する結合性ペプチド
|
|
US8492347B2
(en)
*
|
2007-10-17 |
2013-07-23 |
The Regents Of The University Of California |
Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus
|
|
JP2011503000A
(ja)
*
|
2007-11-02 |
2011-01-27 |
セントコア・オーソ・バイオテツク・インコーポレーテツド |
半合成ＧＬＰ−１ペプチド−Ｆｃ融合コンストラクト、その方法及び使用
|
|
AU2009234277B2
(en)
*
|
2008-04-11 |
2014-12-04 |
Aptevo Research And Development Llc |
CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
|
|
KR101200659B1
(ko)
|
2008-07-23 |
2012-11-12 |
한미사이언스 주식회사 |
세 말단 반응기를 갖는 비펩타이드성 중합체를 이용한 생리활성 폴리펩타이드 약물 결합체
|
|
RU2457856C2
(ru)
*
|
2008-08-05 |
2012-08-10 |
Виктор Владимирович Чалов |
Композиция, обладающая противовирусным и антимикробным действием, для перорального применения
|
|
MX2011001030A
(es)
|
2008-08-07 |
2011-04-26 |
Ipsen Pharma Sas |
Analogos de polipeptidos insulinotropicos dependientes de glucosa.
|
|
US9074014B2
(en)
*
|
2008-08-07 |
2015-07-07 |
Ipsen Pharma S.A.S. |
Analogues of glucose-dependent insulinotropic polypeptide
|
|
EP2318433A4
(en)
*
|
2008-08-07 |
2012-08-08 |
Ipsen Pharma Sas |
GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE ANALOGUES (GIP) MODIFIED AT THE N-TERMINAL END
|
|
WO2010033216A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Polymer conjugates of nesiritide peptides
|
|
MX2011003117A
(es)
*
|
2008-09-19 |
2011-04-21 |
Nektar Therapeutics |
Conjugados polimericos de peptidos terapeuticos.
|
|
WO2010051335A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Amgen Inc. |
Materials and methods relating to stem cell mobilization by multi-pegylated granulocyte colony stimulating factor
|
|
ME02652B
(me)
|
2008-11-26 |
2017-06-20 |
Amgen Inc |
Stabilizovana varijanta aktivin iib receptora
|
|
US20100143353A1
(en)
*
|
2008-12-04 |
2010-06-10 |
Mosser David M |
POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (lgG) AND METHODS OF USING THE SAME
|
|
US20100158893A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Baxter International Inc. |
Systems and methods for obtaining immunoglobulin from blood
|
|
TW201031752A
(en)
*
|
2009-01-19 |
2010-09-01 |
Hanmi Pharm Ind Co Ltd |
Method for producing physiologically active protein or peptide using immunoglobulin fragment
|
|
WO2010096394A2
(en)
|
2009-02-17 |
2010-08-26 |
Redwood Biosciences, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
|
WO2010099153A2
(en)
|
2009-02-25 |
2010-09-02 |
Merck Sharp & Dohme Corp. |
Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris
|
|
CN102427823A
(zh)
*
|
2009-03-24 |
2012-04-25 |
拜耳医药保健有限公司 |
因子viii变体及使用方法
|
|
EP2423233B1
(en)
*
|
2009-04-22 |
2015-03-11 |
Alteogen, Inc |
In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasing in vivo half-life using same
|
|
US20120219538A1
(en)
*
|
2009-11-02 |
2012-08-30 |
Therapeomic Ag |
Stabilized protein formulations and use thereof
|
|
US9629920B2
(en)
|
2009-12-18 |
2017-04-25 |
Exodos Life Sciences Limited Partnership |
Methods and compositions for stable liquid drug formulations
|
|
US8765432B2
(en)
|
2009-12-18 |
2014-07-01 |
Oligasis, Llc |
Targeted drug phosphorylcholine polymer conjugates
|
|
BR112012017982A2
(pt)
*
|
2010-01-19 |
2016-05-03 |
Hanmi Science Co Ltd |
formulações líquidas para conjugado de eritropoietina de longa ação
|
|
JP5657698B2
(ja)
*
|
2010-01-19 |
2015-01-21 |
ハンミ サイエンス カンパニー リミテッドＨａｎｍｉ Ｓｃｉｅｎｃｅｃｏ．，Ｌｔｄ． |
持続型顆粒球コロニー刺激因子結合体の液剤
|
|
WO2011093470A1
(ja)
*
|
2010-01-28 |
2011-08-04 |
協和発酵キリン株式会社 |
Bone morphogenetic protein receptor 1B(BMPR1B)細胞外ドメイン又はその変異体を含む蛋白質を含有する骨疾患治療用医薬組成物
|
|
CN102858949B
(zh)
|
2010-02-24 |
2016-07-06 |
默沙东公司 |
用于增加在巴氏毕赤酵母中生产的治疗性糖蛋白上的n-糖基化位点占据的方法
|
|
EP2544785B1
(en)
*
|
2010-03-08 |
2015-09-30 |
GE Healthcare Bio-Sciences AB |
Immunoglobulin g fc region binding polypeptide
|
|
US9981017B2
(en)
|
2010-04-02 |
2018-05-29 |
Hanmi Science Co., Ltd. |
Insulin conjugate using an immunoglobulin fragment
|
|
AR081066A1
(es)
*
|
2010-04-02 |
2012-06-06 |
Hanmi Holdings Co Ltd |
Conjugado de insulina donde se usa un fragmento de inmunoglobulina
|
|
AR080993A1
(es)
|
2010-04-02 |
2012-05-30 |
Hanmi Holdings Co Ltd |
Formulacion de accion prolongada de interferon beta donde se usa un fragmento de inmunoglobulina
|
|
AR081755A1
(es)
*
|
2010-04-02 |
2012-10-17 |
Hanmi Holdings Co Ltd |
Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
|
|
AU2011245005A1
(en)
|
2010-04-30 |
2012-11-22 |
Alexion Pharma Holding |
Methods, compositions, and kits for the treatment of matrix mineralization disorders
|
|
JP6200806B2
(ja)
*
|
2010-05-21 |
2017-09-20 |
メリマック ファーマシューティカルズ インコーポレーティッド |
二重特異的融合タンパク質
|
|
KR101330868B1
(ko)
*
|
2010-06-08 |
2013-11-18 |
한미사이언스 주식회사 |
면역글로불린 단편을 이용한 인슐린 유도체 약물 결합체
|
|
KR20120002129A
(ko)
*
|
2010-06-30 |
2012-01-05 |
한미홀딩스 주식회사 |
면역글로불린 단편을 이용한 제７인자（Ｆａｃｔｏｒ Ⅶａ）약물 결합체
|
|
KR101337797B1
(ko)
*
|
2010-07-14 |
2013-12-06 |
한미사이언스 주식회사 |
지속형 인간 성장 호르몬 결합체 액상 제제
|
|
KR101382593B1
(ko)
*
|
2010-07-21 |
2014-04-10 |
한미사이언스 주식회사 |
신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물
|
|
MX368531B
(es)
|
2010-07-28 |
2019-10-07 |
Gliknik Inc |
Proteinas de fusion de fragmentos de proteinas humanas naturales para crear composiciones de fc de inmunoglobulinas multimerizadas ordenadamente.
|
|
WO2012053828A2
(ko)
*
|
2010-10-20 |
2012-04-26 |
주식회사 한독약품 |
인간 인터루킨-1 수용체 길항제-하이브리드 Ｆｃ 융합단백질
|
|
KR101333958B1
(ko)
*
|
2010-10-20 |
2013-11-27 |
주식회사 한독 |
인간 인터루킨-1 수용체 길항제-하이브리드 Ｆｃ 융합단백질
|
|
KR101303388B1
(ko)
*
|
2010-10-26 |
2013-09-03 |
한미사이언스 주식회사 |
지속형 인터페론 알파 결합체의 액상 제제
|
|
EP2465536A1
(en)
*
|
2010-12-14 |
2012-06-20 |
CSL Behring AG |
CD89 activation in therapy
|
|
WO2012085111A1
(en)
|
2010-12-23 |
2012-06-28 |
F. Hoffmann-La Roche Ag |
Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
|
|
CA2823066A1
(en)
|
2010-12-27 |
2012-07-05 |
Alexion Pharma International Sarl |
Compositions comprising natriuretic peptides and methods of use thereof
|
|
US9540438B2
(en)
|
2011-01-14 |
2017-01-10 |
Redwood Bioscience, Inc. |
Aldehyde-tagged immunoglobulin polypeptides and methods of use thereof
|
|
CN102309765B
(zh)
*
|
2011-02-28 |
2013-10-16 |
北京韩美药品有限公司 |
包含免疫球蛋白Fc片段作为载体的长效抗凝多肽及其制备方法
|
|
MX343729B
(es)
|
2011-04-08 |
2016-11-18 |
Amgen Inc |
Factor de diferenciación de crecimiento 15 (gdf-15) y composiciones del mismo para usarse en el tratamiento o mejoramiento de trastornos metabólicos.
|
|
UA113626C2
(xx)
*
|
2011-06-02 |
2017-02-27 |
|
Композиція для лікування діабету, що містить кон'югат інсуліну тривалої дії та кон'югат інсулінотропного пептиду тривалої дії
|
|
CN102807619B
(zh)
*
|
2011-06-03 |
2016-08-03 |
北京韩美药品有限公司 |
含有免疫球蛋白Fc片段和粒细胞-巨噬细胞集落刺激因子的复合物及其药物组合物
|
|
RU2739209C2
(ru)
|
2011-06-10 |
2020-12-21 |
Ханми Сайенс Ко., Лтд. |
Новые производные оксинтомодулина и содержащая их фармацевтическая композиция для лечения ожирения
|
|
SI2721062T1
(sl)
|
2011-06-17 |
2019-03-29 |
Hanmi Science Co., Ltd. |
Konjugat, obsegajoč oksintomodulinski in imunoglobinski fragment, in uporaba le-tega
|
|
US9938353B2
(en)
*
|
2011-06-24 |
2018-04-10 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
UA124083C2
(uk)
*
|
2011-06-28 |
2021-07-21 |
ІНГІБРЕКС, Інк. |
Злитий серпіновий поліпептид і спосіб його застосування
|
|
US10400029B2
(en)
|
2011-06-28 |
2019-09-03 |
Inhibrx, Lp |
Serpin fusion polypeptides and methods of use thereof
|
|
BR112013033801A2
(pt)
*
|
2011-06-28 |
2017-12-19 |
Inhibrx Llc |
proteína de fusão isolada, e, método para tratar ou aliviar um sintoma de uma doença ou distúrbio inflamatórios
|
|
CN103611163A
(zh)
*
|
2011-09-05 |
2014-03-05 |
韩美科学株式会社 |
一种包含干扰素α-缀合物的抗癌用药物组合物
|
|
US9458214B2
(en)
|
2011-09-26 |
2016-10-04 |
Novartis Ag |
Dual function fibroblast growth factor 21 proteins
|
|
CA2851223A1
(en)
|
2011-10-06 |
2013-04-11 |
Hanmi Science Co., Ltd. |
Blood coagulation factor vii and viia derivatives, conjugates and complexes comprising the same, and use thereof
|
|
WO2013065343A1
(ja)
*
|
2011-10-31 |
2013-05-10 |
株式会社 島津製作所 |
非ペプチドヒンジ部含有フレキシブル抗体様分子
|
|
KR20130049671A
(ko)
|
2011-11-04 |
2013-05-14 |
한미사이언스 주식회사 |
생리활성 폴리펩타이드 결합체 제조 방법
|
|
JP6145112B2
(ja)
|
2011-12-19 |
2017-06-07 |
アムジエン・インコーポレーテツド |
単独でのまたは化学療法と組み合わされた変異アクチビン受容体ポリペプチド、およびその使用
|
|
CN103172745A
(zh)
*
|
2011-12-21 |
2013-06-26 |
北京韩美药品有限公司 |
包含免疫球蛋白Fc片段的长效人内皮抑素
|
|
KR101895047B1
(ko)
*
|
2011-12-30 |
2018-09-06 |
한미사이언스 주식회사 |
면역글로불린 단편을 이용한 위치 특이적 글루카곤 유사 펩타이드-2 약물 결합체
|
|
KR102041412B1
(ko)
*
|
2011-12-30 |
2019-11-11 |
한미사이언스 주식회사 |
면역글로불린 Ｆｃ 단편 유도체
|
|
JP2015509091A
(ja)
|
2012-01-09 |
2015-03-26 |
ザ スクリプス リサーチ インスティテュート |
ヒト化抗体
|
|
CA2863224A1
(en)
|
2012-01-09 |
2013-07-18 |
The Scripps Research Institute |
Ultralong complementarity determining regions and uses thereof
|
|
US10478508B2
(en)
|
2012-01-10 |
2019-11-19 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
MX2014009129A
(es)
|
2012-01-26 |
2014-11-21 |
Amgen Inc |
Polipeptidos de factor 15 de diferenciacion de crecimiento (gdf-15).
|
|
AR090281A1
(es)
|
2012-03-08 |
2014-10-29 |
Hanmi Science Co Ltd |
Proceso mejorado para la preparacion de un complejo polipeptidico fisiologicamente activo
|
|
KR102142261B1
(ko)
|
2012-03-09 |
2020-08-11 |
체에스엘 베링 아게 |
분비형 면역글로불린을 포함하는 조성물
|
|
EP2636684A1
(en)
|
2012-03-09 |
2013-09-11 |
CSL Behring AG |
Prevention of infection
|
|
EP2636681A1
(en)
|
2012-03-09 |
2013-09-11 |
CSL Behring AG |
Process for enriching IgA
|
|
US10064951B2
(en)
|
2012-03-30 |
2018-09-04 |
Hanmi Science Co., Ltd. |
Liquid formulation of highly concentrated long-acting human growth hormone conjugate
|
|
WO2013162050A1
(ja)
*
|
2012-04-23 |
2013-10-31 |
株式会社Ｎｒｌファーマ |
ラクトフェリン融合タンパク質及びその製造方法
|
|
US10052366B2
(en)
|
2012-05-21 |
2018-08-21 |
Alexion Pharmaceuticsl, Inc. |
Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
|
|
SG11201408161RA
(en)
|
2012-06-08 |
2015-01-29 |
Sutro Biopharma Inc |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
EP3135690A1
(en)
|
2012-06-26 |
2017-03-01 |
Sutro Biopharma, Inc. |
Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
|
|
KR20150030744A
(ko)
*
|
2012-06-27 |
2015-03-20 |
에프. 호프만-라 로슈 아게 |
표적에 특이적으로 결합하는 하나 이상의 결합 단위를 포함하는 항체 Ｆｃ－영역 접합체의 제조 방법 및 그의 용도
|
|
RU2639287C2
(ru)
|
2012-06-27 |
2017-12-20 |
Ф. Хоффманн-Ля Рош Аг |
Способ отбора и получения высокоселективных и мультиспецифичных нацеливающих групп с заданными свойствами, включающих по меньшей мере две различные связывающие группировки, и их применения
|
|
AR091902A1
(es)
|
2012-07-25 |
2015-03-11 |
Hanmi Pharm Ind Co Ltd |
Formulacion liquida de un conjugado de insulina de accion prolongada
|
|
AR094821A1
(es)
*
|
2012-07-25 |
2015-09-02 |
Hanmi Pharm Ind Co Ltd |
Formulación líquida de un conjugado de péptido insulinotrópico de acción prolongada
|
|
KR101968344B1
(ko)
|
2012-07-25 |
2019-04-12 |
한미약품 주식회사 |
옥신토모듈린 유도체를 포함하는 고지혈증 치료용 조성물
|
|
AR092862A1
(es)
|
2012-07-25 |
2015-05-06 |
Hanmi Pharm Ind Co Ltd |
Formulacion liquida de insulina de accion prolongada y un peptido insulinotropico y metodo de preparacion
|
|
US10441665B2
(en)
|
2012-07-25 |
2019-10-15 |
Hanmi Pharm. Co., Ltd. |
Liquid formulation of long acting insulinotropic peptide conjugate
|
|
WO2014031646A2
(en)
|
2012-08-20 |
2014-02-27 |
Gliknik Inc. |
Molecules with antigen binding and polyvalent fc gamma receptor binding activity
|
|
ES2728864T3
(es)
|
2012-08-31 |
2019-10-29 |
Sutro Biopharma Inc |
Aminoácidos modificados que comprenden un grupo azido
|
|
WO2014043523A1
(en)
*
|
2012-09-14 |
2014-03-20 |
The Johns Hopkins University |
Compositions and methods for rendering tumor cells susceptible to cd8+ t cell-mediated killing
|
|
WO2014041072A1
(en)
|
2012-09-14 |
2014-03-20 |
F. Hoffmann-La Roche Ag |
Method for the production and selection of molecules comprising at least two different entities and uses thereof
|
|
US9724420B2
(en)
|
2012-11-06 |
2017-08-08 |
Hanmi Pharm. Co., Ltd. |
Liquid formulation of protein conjugate comprising an oxyntomodulin derivative covalently linked to a non-peptidyl polymer to an immunoglobulin FC region
|
|
KR101993393B1
(ko)
*
|
2012-11-06 |
2019-10-01 |
한미약품 주식회사 |
옥신토모듈린 유도체를 포함하는 당뇨병 또는 비만성 당뇨병 치료용 조성물
|
|
WO2014110368A1
(en)
*
|
2013-01-11 |
2014-07-17 |
The California Institute For Biomedical Research |
Bovine fusion antibodies
|
|
CN103217489B
(zh)
*
|
2013-01-15 |
2016-03-09 |
珠海市丽珠单抗生物技术有限公司 |
一种测定蛋白纯化工艺过程中样品的糖基化和末端修饰情况的方法
|
|
KR102073748B1
(ko)
|
2013-01-31 |
2020-02-05 |
한미약품 주식회사 |
재조합 효모 형질전환체 및 이를 이용하여 면역글로불린 단편을 생산하는 방법
|
|
CA2899889A1
(en)
|
2013-02-01 |
2014-08-07 |
Santa Maria Biotherapeutics, Inc. |
Administration of an anti-activin-a compound to a subject
|
|
JP2016511768A
(ja)
*
|
2013-02-22 |
2016-04-21 |
ゾエティス・サービシーズ・エルエルシー |
家禽類の成績を改善するための成長因子の卵内投与
|
|
PT2966083T
(pt)
|
2013-03-05 |
2019-09-17 |
Hanmi Pharm Ind Co Ltd |
Método de preparação melhorado para produção de alto rendimento de conjugado de polipéptido fisiologicamente ativo
|
|
WO2014139994A1
(en)
|
2013-03-11 |
2014-09-18 |
Novo Nordisk Health Care Ag |
Growth hormone compounds
|
|
US20140271641A1
(en)
*
|
2013-03-14 |
2014-09-18 |
University Of Guelph |
Thrombospondin-1 polypeptides and methods of using same
|
|
EA037906B1
(ru)
|
2013-03-15 |
2021-06-04 |
Биовератив Терапьютикс Инк. |
Препараты полипептида фактора ix
|
|
ES2708565T3
(es)
|
2013-03-15 |
2019-04-10 |
Atyr Pharma Inc |
Conjugados de Fc-histidil-ARNt sintetasa
|
|
KR101895634B1
(ko)
*
|
2013-05-31 |
2018-09-05 |
한미약품 주식회사 |
변이된 힌지 영역을 포함하는 IgG4 Fc 단편
|
|
ES2658039T3
(es)
|
2013-07-10 |
2018-03-08 |
Sutro Biopharma, Inc. |
Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso
|
|
AR096890A1
(es)
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugando fc de inmunoglobulina, que mantiene la afinidad de unión del fragmento fc de la inmunoglobulina a fcrn
|
|
AR096891A1
(es)
*
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo
|
|
CN105814074B
(zh)
|
2013-07-18 |
2020-04-21 |
图鲁斯生物科学有限责任公司 |
具有超长互补决定区的人源化抗体
|
|
US9862752B2
(en)
*
|
2013-07-31 |
2018-01-09 |
Amgen Inc. |
Growth differentiation factor 15 (GDF-15) constructs
|
|
AU2014312190A1
(en)
|
2013-08-28 |
2016-02-18 |
Bioasis Technologies Inc. |
CNS-targeted conjugates of antibodies
|
|
JP6463361B2
(ja)
|
2013-09-08 |
2019-01-30 |
コディアック サイエンシーズ インコーポレイテッドＫｏｄｉａｋ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． |
第ｖｉｉｉ因子両性イオンポリマーコンジュゲート
|
|
JP6886816B2
(ja)
|
2013-09-09 |
2021-06-16 |
カニムガイド セラピューティックス アーベー |
免疫系調節薬
|
|
WO2015046974A1
(ko)
|
2013-09-27 |
2015-04-02 |
한미약품 주식회사 |
지속형 인간 성장 호르몬 제제
|
|
CN105579637B
(zh)
*
|
2013-09-30 |
2018-04-10 |
3M创新有限公司 |
具有设置于其上的环氧化脂肪酸酯的纤维和擦拭物以及方法
|
|
CA2930243A1
(en)
|
2013-11-11 |
2015-05-14 |
Wake Forest University Health Sciences |
Epha3 and multi-valent targeting of tumors
|
|
MX369656B
(es)
|
2014-01-20 |
2019-11-15 |
Hanmi Pharm Ind Co Ltd |
Insulina de accion prolongada y uso de la misma.
|
|
US10421796B2
(en)
*
|
2014-01-21 |
2019-09-24 |
Gray D Shaw |
Variants of IgG Fc with limited amine groups
|
|
DK3127923T3
(da)
*
|
2014-03-31 |
2021-11-22 |
Hanmi Pharm Ind Co Ltd |
Fremgangsmåde til forbedring af oppløselighed af protein og peptid ved hjælp af immunoglobulin-fc-fragment-binding
|
|
PT3129406T
(pt)
*
|
2014-04-11 |
2019-04-24 |
Medimmune Llc |
Compostos conjugados que compreendem anticorpos com manipulação de cisteínas
|
|
CN106536548A
(zh)
*
|
2014-04-28 |
2017-03-22 |
国家生物技术研究所公司 |
Dr3变体及其用途
|
|
KR20150133576A
(ko)
*
|
2014-05-20 |
2015-11-30 |
삼성전자주식회사 |
화학적 개질된 표적화 단백질 및 그의 이용
|
|
AR100639A1
(es)
|
2014-05-29 |
2016-10-19 |
Hanmi Pharm Ind Co Ltd |
Composición para tratar diabetes que comprende conjugados de análogos de insulina de acción prolongada y conjugados de péptidos insulinotrópicos de acción prolongada
|
|
TWI684458B
(zh)
|
2014-05-30 |
2020-02-11 |
南韓商韓美藥品股份有限公司 |
包含胰島素及ｇｌｐ-１/昇糖素雙重促效劑之治療糖尿病之組成物
|
|
DK3160994T3
(da)
*
|
2014-06-27 |
2025-05-05 |
Innate Pharma |
Multispecifikke antigenbindende proteiner
|
|
US10519234B2
(en)
|
2014-06-27 |
2019-12-31 |
Innate Pharma |
NKp46 binding proteins
|
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
|
US10822596B2
(en)
|
2014-07-11 |
2020-11-03 |
Alexion Pharmaceuticals, Inc. |
Compositions and methods for treating craniosynostosis
|
|
RU2021106673A
(ru)
*
|
2014-07-24 |
2021-11-25 |
Дженентек, Инк. |
Способы конъюгации агента с тиольным компонентом в белке, который содержит по меньшей мере одну трисульфидную связь
|
|
TWI802396B
(zh)
|
2014-09-16 |
2023-05-11 |
南韓商韓美藥品股份有限公司 |
長效glp-1/高血糖素受體雙促效劑治療非酒精性脂肝疾病之用途
|
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
|
JP6849590B2
(ja)
*
|
2014-10-17 |
2021-03-24 |
コディアック サイエンシーズ インコーポレイテッドＫｏｄｉａｋ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． |
ブチリルコリンエステラーゼ両性イオン性ポリマーコンジュゲート
|
|
CA2967851C
(en)
|
2014-12-05 |
2024-02-27 |
Alexion Pharmaceuticals, Inc. |
Treating seizure with recombinant alkaline phosphatase
|
|
KR102418477B1
(ko)
|
2014-12-30 |
2022-07-08 |
한미약품 주식회사 |
글루카곤 유도체
|
|
AR103322A1
(es)
|
2014-12-30 |
2017-05-03 |
Hanmi Pharm Ind Co Ltd |
Derivados de glucagón con estabilidad mejorada
|
|
US10603361B2
(en)
|
2015-01-28 |
2020-03-31 |
Alexion Pharmaceuticals, Inc. |
Methods of treating a subject with an alkaline phosphatase deficiency
|
|
ES2853582T3
(es)
|
2015-03-06 |
2021-09-16 |
Canimguide Therapeutics Ab |
Moduladores del sistema inmune y composiciones
|
|
JP6810702B2
(ja)
|
2015-04-06 |
2021-01-06 |
アクセルロン ファーマ インコーポレイテッド |
シングルアームｉ型およびｉｉ型受容体融合タンパク質およびその使用
|
|
RS61881B1
(sr)
|
2015-04-22 |
2021-06-30 |
Biogen Ma Inc |
Novi hibridni actriib proteini zamke za ligand za lečenje bolesti gubljenja mišića
|
|
CA2979973A1
(en)
*
|
2015-04-29 |
2016-11-03 |
Mediolanum Farmaceutici S.P.A. |
A soluble chimeric interleukin-10 receptor and therapeutic use thereof
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
WO2016193380A1
(en)
|
2015-06-02 |
2016-12-08 |
Novo Nordisk A/S |
Insulins with polar recombinant extensions
|
|
US11820807B2
(en)
*
|
2015-06-12 |
2023-11-21 |
Ubi Pharma Inc |
Immunoglobulin fusion proteins and uses thereof
|
|
CA2989116A1
(en)
*
|
2015-06-12 |
2016-12-15 |
Ubi Pharma Inc |
Immunoglobulin fusion proteins and uses thereof
|
|
CA2990518A1
(en)
|
2015-06-23 |
2016-12-29 |
Innate Pharma |
Multispecific nk engager proteins
|
|
CR20180034A
(es)
|
2015-06-30 |
2018-04-16 |
Hanmi Pharm Ind Co Ltd |
Derivados de glucagón y una composición que comprende un conjugado de acción prolongada del mismo.
|
|
KR20170012145A
(ko)
|
2015-07-24 |
2017-02-02 |
한미약품 주식회사 |
생리활성폴리펩타이드 결합체의 제조방법
|
|
MX394116B
(es)
|
2015-07-24 |
2025-03-19 |
Gliknik Inc |
Proteinas de fusion de fragmentos de proteina humana para crear composiciones de fc de inmunoglobulina multimerizada de forma ordenada con union al complemento aumentada.
|
|
RU2745528C2
(ru)
|
2015-08-17 |
2021-03-26 |
Алексион Фармасьютикалз, Инк. |
Производство щелочных фосфатаз
|
|
UY36870A
(es)
|
2015-08-28 |
2017-03-31 |
Hanmi Pharm Ind Co Ltd |
Análogos de insulina novedosos
|
|
WO2017053469A2
(en)
|
2015-09-21 |
2017-03-30 |
Aptevo Research And Development Llc |
Cd3 binding polypeptides
|
|
EP4534107A3
(en)
*
|
2015-09-24 |
2025-12-10 |
Hanmi Pharm. Co., Ltd. |
Protein complex by use of a specific site of an immunoglobulin fragment for linkage
|
|
TW201718629A
(zh)
*
|
2015-09-25 |
2017-06-01 |
韓美藥品股份有限公司 |
包含多個生理多肽及免疫球蛋白Ｆｃ區之蛋白質接合物
|
|
WO2017058822A1
(en)
|
2015-09-28 |
2017-04-06 |
Alexion Pharmaceuticals, Inc. |
Identifying effective dosage regimens for tissue non-specific alkaline phosphatase (tnsalp)-enzyme replacement therapy of hypophosphatasia
|
|
MA43348A
(fr)
|
2015-10-01 |
2018-08-08 |
Novo Nordisk As |
Conjugués de protéines
|
|
CN116063566A
(zh)
|
2015-10-01 |
2023-05-05 |
热生物制品有限公司 |
作为异源嵌合蛋白邻接i型和ii型胞外结构域的组合物和方法
|
|
US10040840B2
(en)
*
|
2015-10-02 |
2018-08-07 |
Silver Creek Pharmaceuticals, Inc. |
Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue
|
|
US20170095577A1
(en)
*
|
2015-10-06 |
2017-04-06 |
Washington University |
Noninvasive imaging of focal atherosclerotic lesions using fluorescence molecular tomography
|
|
WO2017074466A1
(en)
|
2015-10-30 |
2017-05-04 |
Alexion Pharmaceuticals, Inc. |
Methods for treating craniosynostosis in a patient
|
|
EP3395366B1
(en)
*
|
2015-12-21 |
2023-11-22 |
Hefei Lifeon Pharmaceutical Co., Ltd. |
Drug design method, obtained drug and application thereof
|
|
WO2017117464A1
(en)
|
2015-12-30 |
2017-07-06 |
Kodiak Sciences Inc. |
Antibodies and conjugates thereof
|
|
KR20170079409A
(ko)
*
|
2015-12-30 |
2017-07-10 |
한미약품 주식회사 |
지속형 인간 성장 호르몬 결합체의 신규 액상 제제
|
|
AU2016382394B2
(en)
|
2015-12-31 |
2019-07-04 |
Hanmi Pharm. Co., Ltd. |
Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist
|
|
US11708413B2
(en)
|
2016-01-27 |
2023-07-25 |
Sutro Biopharma, Inc. |
Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates
|
|
AR107483A1
(es)
*
|
2016-01-29 |
2018-05-02 |
Hanmi Pharm Ind Co Ltd |
Conjugado de enzimas terapéuticas
|
|
EP3426286A4
(en)
|
2016-03-08 |
2019-12-04 |
Alexion Pharmaceuticals, Inc. |
PROCESS FOR TREATING HYPOPHOSPHATASIA IN CHILDREN
|
|
EP3436020A4
(en)
|
2016-04-01 |
2019-12-25 |
Alexion Pharmaceuticals, Inc. |
METHOD FOR TREATING HYPOPHOSPHATASIE IN TEENS AND ADULTS
|
|
JP7613826B2
(ja)
|
2016-04-01 |
2025-01-15 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
アルカリホスファターゼによって筋力低下を治療すること
|
|
JP2019515677A
(ja)
|
2016-04-26 |
2019-06-13 |
アール．ピー．シェーラー テクノロジーズ エルエルシー |
抗体複合体ならびにそれを作製および使用する方法
|
|
WO2017191817A1
(ja)
|
2016-05-02 |
2017-11-09 |
味の素株式会社 |
アジド基含有Ｆｃタンパク質
|
|
CN106008722B
(zh)
*
|
2016-05-13 |
2019-10-15 |
未名生物医药有限公司 |
一种重组β-hNGF-Fc融合蛋白、制备方法及用途
|
|
US10988744B2
(en)
|
2016-06-06 |
2021-04-27 |
Alexion Pharmaceuticals, Inc. |
Method of producing alkaline phosphatase
|
|
EP3464347B1
(en)
|
2016-06-07 |
2023-05-31 |
Gliknik Inc. |
Cysteine-optimized stradomers
|
|
PE20190355A1
(es)
|
2016-06-29 |
2019-03-07 |
Hanmi Pharm Ind Co Ltd |
Derivado de glucagon, conjugado del mismo, composicion que comprende el mismo y uso terapeutico del mismo
|
|
EP3500289B1
(en)
|
2016-08-18 |
2024-10-09 |
Alexion Pharmaceuticals, Inc. |
Asfotase alfa for use in treating tracheobronchomalacia
|
|
JOP20190019A1
(ar)
*
|
2016-08-30 |
2019-02-12 |
Genexine Inc |
تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH)
|
|
AU2017332408B2
(en)
|
2016-09-23 |
2022-02-10 |
Hanmi Pharm. Co., Ltd. |
Insulin analogs with reduced affinity to insulin receptor and use thereof
|
|
JOP20190085A1
(ar)
|
2016-10-20 |
2019-04-17 |
Biogen Ma Inc |
طرق علاج الضمور العضلي ومرض العظام باستخدام بروتينات احتجاز مركب ترابطي actriib هجين حديثة
|
|
KR20180064321A
(ko)
*
|
2016-12-05 |
2018-06-14 |
한미약품 주식회사 |
면역반응이 약화된 결합체
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
AU2017371182B2
(en)
|
2016-12-09 |
2024-03-28 |
Gliknik Inc. |
Methods of treating inflammatory disorders with multivalent Fc compounds
|
|
AU2017371179B2
(en)
|
2016-12-09 |
2022-07-14 |
Gliknik Inc. |
Manufacturing optimization of GL-2045, a multimerizing stradomer
|
|
KR102645064B1
(ko)
*
|
2017-02-03 |
2024-03-08 |
한미약품 주식회사 |
지속성이 증가된 생리활성 물질의 결합체 및 이의 용도
|
|
CN110234345A
(zh)
|
2017-02-27 |
2019-09-13 |
沙塔克实验室有限公司 |
制备和使用基于细胞外结构域的嵌合蛋白的方法
|
|
CN110381974A
(zh)
*
|
2017-02-27 |
2019-10-25 |
沙塔克实验室有限公司 |
基于csf1r的嵌合蛋白
|
|
AU2018239037B2
(en)
|
2017-03-23 |
2022-05-26 |
Hanmi Pharm. Co., Ltd. |
Insulin analog complex with reduced affinity for insulin receptor and use thereof
|
|
CA3057502A1
(en)
|
2017-03-31 |
2018-10-04 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia (hpp) in adults and adolescents
|
|
WO2018185131A2
(en)
*
|
2017-04-05 |
2018-10-11 |
Novo Nordisk A/S |
Oligomer extended insulin-fc conjugates
|
|
WO2018193033A1
(en)
*
|
2017-04-20 |
2018-10-25 |
Novo Nordisk A/S |
Methods of purification of albumin fusion proteins
|
|
EP3612215B1
(en)
|
2017-04-20 |
2024-08-28 |
aTyr Pharma, Inc. |
Compositions for treating lung inflammation
|
|
CN109206522B
(zh)
*
|
2017-07-07 |
2021-11-09 |
北京三有利和泽生物科技有限公司 |
一种长效抗凝血融合蛋白及其应用
|
|
JP6566324B2
(ja)
*
|
2017-09-29 |
2019-08-28 |
サイデン化学株式会社 |
粘着シート
|
|
CN111406073A
(zh)
*
|
2017-09-29 |
2020-07-10 |
韩美药品株式会社 |
具有提高功效的持久性蛋白质缀合物
|
|
BR112020005271A2
(pt)
|
2017-10-02 |
2020-09-15 |
Denali Therapeutics Inc. |
proteína, polipeptídeo, polinucleotídeo, vetor, célula hospedeira, método para produção de um polipeptídeo, métodos de tratamento de um distúrbio, de diminuição do acúmulo, de monitoramento, de transporte de um agente e de tratamento de um lsd e composição farmacêutica
|
|
KR20190045081A
(ko)
*
|
2017-10-23 |
2019-05-02 |
주식회사 프로젠 |
변형된 egf 단백질 및 이를 유효성분으로 포함하는 피부 상태 개선용 화장료 조성물
|
|
KR102167827B1
(ko)
*
|
2017-12-20 |
2020-10-20 |
주식회사 알테오젠 |
신규한 성장 호르몬 수용체 길항제 및 이의 융합 단백질
|
|
CN108218998A
(zh)
*
|
2017-12-31 |
2018-06-29 |
武汉班科生物技术股份有限公司 |
一种突变型人源IgG的Fc片段及其制备方法与应用
|
|
KR101974305B1
(ko)
*
|
2018-02-14 |
2019-04-30 |
한미사이언스 주식회사 |
생리활성 폴리펩타이드 결합체 제조 방법
|
|
BR112020017872A2
(pt)
|
2018-03-02 |
2020-12-22 |
Kodiak Sciences Inc. |
Anticorpos de il-6 e construtos de fusão e conjugados dos mesmos
|
|
KR20250121150A
(ko)
*
|
2018-03-26 |
2025-08-11 |
리제너론 파마슈티칼스 인코포레이티드 |
치료제를 시험하기 위한 인간화된 설치류
|
|
KR102209108B1
(ko)
|
2018-03-27 |
2021-01-28 |
국립암센터 |
Oct4 기능 저해용 펩티드를 포함하는 줄기세포성 억제용 조성물
|
|
JP2021519590A
(ja)
|
2018-03-30 |
2021-08-12 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
糖タンパク質の製造
|
|
KR20200140878A
(ko)
|
2018-04-09 |
2020-12-16 |
암젠 인크 |
성장 분화 인자 15 융합 단백질
|
|
JP2021534111A
(ja)
|
2018-08-10 |
2021-12-09 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
アルカリホスファターゼを用いて神経線維腫症１型および関連状態を治療する方法
|
|
US10780121B2
(en)
|
2018-08-29 |
2020-09-22 |
Shattuck Labs, Inc. |
FLT3L-based chimeric proteins
|
|
TW202337914A
(zh)
*
|
2019-04-23 |
2023-10-01 |
南韓商Ｌｇ化學股份有限公司 |
融合多肽及其用途與製備方法、核酸分子、重組載體、重組細胞以及用於增強生長/分化因子15或其功能變體的活體內穩定性的方法
|
|
US11267858B2
(en)
*
|
2019-05-31 |
2022-03-08 |
Spectrum Pharmaceuticals, Inc. |
Methods of treatment using G-CSF protein complex
|
|
CN112142850A
(zh)
*
|
2019-06-27 |
2020-12-29 |
深圳市卫光生物制品股份有限公司 |
人神经生长因子-乳铁蛋白重组蛋白及用途
|
|
WO2021072265A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
|
CN110669134A
(zh)
*
|
2019-10-15 |
2020-01-10 |
广东菲鹏生物有限公司 |
IgM-FC片段、IgM-FC抗体及制备方法和应用
|
|
US12433938B2
(en)
|
2019-12-09 |
2025-10-07 |
Alexion Pharmaceuticals, Inc. |
Alkaline phosphatase polypeptides and methods of use thereof
|
|
BR112022011540A2
(pt)
*
|
2019-12-11 |
2022-09-06 |
Lg Chemical Ltd |
Polipeptídeo de fusão compreendendo gdf15, composição farmacêutica que compreende o mesmo, dímero e método de preparação do dito polipeptídeo, método para aumentar a estabilidade in vivo de gdf15, molécula de ácido nucleico, vetor e célula recombinantes e uso terapêutico do dito polipeptídeo e dímero
|
|
CN111153996B
(zh)
*
|
2020-01-10 |
2021-12-14 |
苏州睿瀛生物技术有限公司 |
G蛋白偶联受体的抗体及其制备方法和g蛋白偶联受体试剂盒
|
|
CN111505291B
(zh)
*
|
2020-04-14 |
2023-04-25 |
山东省千佛山医院 |
一种排除巨酶分子对血清酶浓度检测带来干扰的方法
|
|
US20230210949A1
(en)
|
2020-05-22 |
2023-07-06 |
Hanmi Pharm Co., Ltd. |
Liquid formulation
|
|
CN112098639B
(zh)
*
|
2020-09-21 |
2024-01-02 |
天津医科大学 |
以氧化石墨烯为载体的二抗的合成及应用
|
|
EP4240423A1
(en)
*
|
2020-11-03 |
2023-09-13 |
Protalix Ltd. |
Modified uricase and uses thereof
|
|
AU2022218782A1
(en)
|
2021-02-12 |
2023-08-17 |
Alexion Pharmaceuticals, Inc. |
Alkaline phosphatase polypeptides and methods of use thereof
|
|
US20240425606A1
(en)
|
2021-08-30 |
2024-12-26 |
Lassen Therapeutics 1, Inc. |
Anti-il-11ra antibodies
|
|
IL314551A
(en)
*
|
2022-01-28 |
2024-09-01 |
argenx BV |
Use of anti-MUSK antibodies to treat neuromuscular disorders
|
|
IL315251A
(en)
*
|
2022-03-03 |
2024-10-01 |
Univ Pennsylvania |
Viral vectors encoding parathyroid hormone fusions and their uses for the treatment of hypoparathyroidism
|
|
CN114588315A
(zh)
*
|
2022-03-14 |
2022-06-07 |
东莞市人民医院 |
抗炎蛋白涂层的制备方法、生物工程功能材料及其应用
|
|
AU2023391468A1
(en)
*
|
2022-12-05 |
2025-07-17 |
Alexion Pharmaceuticals, Inc. |
Taci-fc fusion proteins for multifunctional inhibition of baff, april, and neonatal fc receptor
|
|
CN120530131A
(zh)
|
2023-01-06 |
2025-08-22 |
拉森医疗公司 |
抗il-18bp抗体
|
|
CN120787238A
(zh)
|
2023-01-06 |
2025-10-14 |
拉森医疗公司 |
用于治疗甲状腺眼病的抗IL-11Rα抗体
|
|
TW202430560A
(zh)
|
2023-01-06 |
2024-08-01 |
美商拉森醫療公司 |
抗ｉｌ－１８ｂｐ抗體
|